Te‐Chun Hsia
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Lung Cancer Treatments and Mutations 38
- Lung Cancer Diagnosis and Treatment 13
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
-
- DNA Repair Mechanisms 9
- Genomics, phytochemicals, and oxidative stress 6
- Co-authors
- Jing‐Gung Chung (16 shared papers)Chih‐Yen Tu (41 shared papers)Te‐Chun Shen (36 shared papers)DA-TIAN BAU (39 shared papers)Jai‐Sing Yang (6 shared papers)Chia‐Hung Chen (25 shared papers)Wu‐Huei Hsu (15 shared papers)M. Eric Gershwin (1 shared paper)
- Journals
- Anticancer Research (17 papers)Journal of Clinical Oncology (9 papers)Medicine (7 papers)Environmental Toxicology (4 papers)BMC Cancer (3 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Te‐Chun Hsia
148 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 112
- Applied Microbiology and Biotechnology 48
- Cancer Research 268
- Periodontics 81
- Oncology 462
- Pulmonary and Respiratory Medicine 513
Countries citing papers authored by Te‐Chun Hsia
This map shows the geographic impact of Te‐Chun Hsia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Chun Hsia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Chun Hsia more than expected).
Fields of papers citing papers by Te‐Chun Hsia
This network shows the impact of papers produced by Te‐Chun Hsia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Chun Hsia. The network helps show where Te‐Chun Hsia may publish in the future.
Co-authors
The 25 scholars most cited alongside Te‐Chun Hsia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 199 | |
| 2 | 2021 | 173 | |
| 3 | Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. | 1996 | 117 |
| 4 | 2011 | 105 | |
| 5 | 2019 | 86 | |
| 6 | 2003 | 59 | |
| 7 | Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. | 2002 | 56 |
| 8 | 2017 | 47 | |
| 9 | 2016 | 45 | |
| 10 | 2015 | 41 | |
| 11 | Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. | 2010 | 37 |
| 12 | 2012 | 35 | |
| 13 | The joint effect of hOGG1 single nucleotide polymorphism and smoking habit on lung cancer in Taiwan. | 2010 | 34 |
| 14 | 2001 | 34 | |
| 15 | 2016 | 32 | |
| 16 | 2019 | 31 | |
| 17 | 2017 | 30 | |
| 18 | 2015 | 26 | |
| 19 | 2014 | 26 | |
| 20 | 2017 | 25 |
About Te‐Chun Hsia
Te‐Chun Hsia is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Epidemiology, having authored 156 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (13 papers), DNA Repair Mechanisms (9 papers), Protease and Inhibitor Mechanisms (9 papers), Asthma and respiratory diseases (9 papers), Lung Cancer Research Studies (8 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (48 citations), Cancer Research (268 citations), Periodontics (81 citations), Oncology (462 citations) and Pulmonary and Respiratory Medicine (513 citations). Te‐Chun Hsia has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Jing‐Gung Chung, Chih‐Yen Tu, Te‐Chun Shen, DA-TIAN BAU, Jai‐Sing Yang, Chia‐Hung Chen, Wu‐Huei Hsu, M. Eric Gershwin, Michael Blankenburg and Thomas Prindiville. Their work appears in journals such as Anticancer Research, Journal of Clinical Oncology, Medicine, Environmental Toxicology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.